IMRX AS OF 07/31/2021

Company

Immuneering Corp

Filed

August 10, 2021

Accession Number

0000080255-21-001435

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →